317 related articles for article (PubMed ID: 31430188)
41. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.
Frank SJ; Blanchard P; Lee JJ; Sturgis EM; Kies MS; Machtay M; Vikram B; Garden AS; Rosenthal DI; Gunn GB; Fuller CD; Hutcheson K; Lai S; Busse PM; Lee NY; Lin A; Foote RL
Semin Radiat Oncol; 2018 Apr; 28(2):108-113. PubMed ID: 29735186
[TBL] [Abstract][Full Text] [Related]
42. Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?
Liao Z; Gandhi SJ; Lin SH; Bradley J
Semin Radiat Oncol; 2018 Apr; 28(2):114-124. PubMed ID: 29735187
[TBL] [Abstract][Full Text] [Related]
43. Clinical controversies: proton therapy for thoracic tumors.
De Ruysscher D; Chang JY
Semin Radiat Oncol; 2013 Apr; 23(2):115-9. PubMed ID: 23473688
[TBL] [Abstract][Full Text] [Related]
44. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
45. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
46. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
47. The use of proton therapy in the treatment of lung cancers.
Simone CB; Rengan R
Cancer J; 2014; 20(6):427-32. PubMed ID: 25415690
[TBL] [Abstract][Full Text] [Related]
48. [Intensity-modulated radiation therapy in non-small cell lung cancers].
Ayadi M; Zahra N; Thariat J; Bouilhol G; Boissard P; Van Houtte P; Claude L; Mornex F
Cancer Radiother; 2014 Oct; 18(5-6):406-13. PubMed ID: 25219608
[TBL] [Abstract][Full Text] [Related]
49. Analysis of dose distribution in the 'Rind'--a volume outside the PTV--in 3-dimensional conformal radiation therapy of non-small cell lung cancer.
McGibney C; Holmberg O; McClean B; Armstrong J
Radiother Oncol; 2003 Jan; 66(1):87-93. PubMed ID: 12559525
[TBL] [Abstract][Full Text] [Related]
50. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
Seco J; Panahandeh HR; Westover K; Adams J; Willers H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
[TBL] [Abstract][Full Text] [Related]
51. [Non-small-cell bronchial cancers: improvement of survival probability by conformal radiotherapy].
Giraud P; Helfre S; Lavole A; Rosenwald JC; Cosset JM
Cancer Radiother; 2002 Nov; 6 Suppl 1():125s-134s. PubMed ID: 12587391
[TBL] [Abstract][Full Text] [Related]
52. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
Cozzi L; Fogliata A; Lomax A; Bolsi A
Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
[TBL] [Abstract][Full Text] [Related]
53. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
54. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
[TBL] [Abstract][Full Text] [Related]
55. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
[TBL] [Abstract][Full Text] [Related]
56. Do protons have a role in the treatment of locally advanced NSCLC with radiotherapy?
McDonald F; Hanna GG
Lung Cancer; 2017 Aug; 110():71-73. PubMed ID: 28624125
[No Abstract] [Full Text] [Related]
57. A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.
Hoppe BS; Henderson R; Pham D; Cury JD; Bajwa A; Morris CG; D'Agostino H; Flampouri S; Huh S; Li Z; McCook B; Nichols RC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):517-522. PubMed ID: 26774428
[TBL] [Abstract][Full Text] [Related]
58. Recent advances in intensity modulated radiotherapy and proton therapy for esophageal cancer.
Xi M; Lin SH
Expert Rev Anticancer Ther; 2017 Jul; 17(7):635-646. PubMed ID: 28503964
[TBL] [Abstract][Full Text] [Related]
59. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.
Fuss M; Hug EB; Schaefer RA; Nevinny-Stickel M; Miller DW; Slater JM; Slater JD
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1117-26. PubMed ID: 10613303
[TBL] [Abstract][Full Text] [Related]
60. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
